[{"address1": "150 West 4th Ave", "city": "Vancouver", "state": "BC", "zip": "V5Y 1G6", "country": "Canada", "phone": "604 559 9005", "website": "https://www.abcellera.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.", "fullTimeEmployees": 596, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carl L.G. Hansen Ph.D.", "age": 49, "title": "CEO, President & Chairperson", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 746836, "exercisedValue": 210706, "unexercisedValue": 2408685}, {"maxAge": 1, "name": "Mr. Andrew  Booth M.B.A.", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 671720, "exercisedValue": 0, "unexercisedValue": 12299500}, {"maxAge": 1, "name": "Dr. Veronique  Lecault Ph.D.", "age": 39, "title": "CTO & Director", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 667706, "exercisedValue": 230210, "unexercisedValue": 1260000}, {"maxAge": 1, "name": "Mr. Tryn T. Stimart Esq., J.D., M.Sc.", "age": 54, "title": "Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 685080, "exercisedValue": 0, "unexercisedValue": 3502170}, {"maxAge": 1, "name": "Ms. Tiffany  Chiu B.Sc., Ph.D.", "title": "Vice President of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Graham  Craig M.Sc.", "title": "Director of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Murray  McCutcheon Ph.D.", "title": "Senior Vice President of Partnering", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Neil  Aubuchon B.A., M.B.A.", "age": 54, "title": "Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 684813, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adam  Clarke M.A.I.C.D., Ph.D.", "title": "Senior Vice President of Discovery", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Colussi Ph.D.", "title": "Site Head & Vice President of Australia", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 5, "overallRisk": 7, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.3, "open": 4.28, "dayLow": 4.22, "dayHigh": 4.53, "regularMarketPreviousClose": 4.3, "regularMarketOpen": 4.28, "regularMarketDayLow": 4.22, "regularMarketDayHigh": 4.53, "payoutRatio": 0.0, "beta": 0.649, "forwardPE": -6.6515145, "volume": 4110940, "regularMarketVolume": 4110940, "averageVolume": 6485054, "averageVolume10days": 5237740, "averageDailyVolume10Day": 5237740, "bid": 4.35, "ask": 4.41, "bidSize": 16, "askSize": 91, "marketCap": 1311876736, "fiftyTwoWeekLow": 1.891, "fiftyTwoWeekHigh": 5.82, "priceToSalesTrailing12Months": 39.90378, "fiftyDayAverage": 4.1362, "twoHundredDayAverage": 3.032575, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 900878464, "profitMargins": 0.0, "floatShares": 202749166, "sharesOutstanding": 298832992, "sharesShort": 39805894, "sharesShortPriorMonth": 30416351, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.1333, "heldPercentInsiders": 0.22941999, "heldPercentInstitutions": 0.38522, "shortRatio": 5.88, "shortPercentOfFloat": 0.173, "impliedSharesOutstanding": 298832992, "bookValue": 3.405, "priceToBook": 1.2892804, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -165664992, "trailingEps": -0.56, "forwardEps": -0.66, "enterpriseToRevenue": 27.402, "enterpriseToEbitda": -4.125, "52WeekChange": 0.6319703, "SandP52WeekChange": 0.1513431, "quoteType": "EQUITY", "currentPrice": 4.39, "targetHighPrice": 17.0, "targetLowPrice": 5.0, "targetMeanPrice": 9.28571, "targetMedianPrice": 9.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 553078016, "totalCashPerShare": 1.851, "ebitda": -218379008, "totalDebt": 142080000, "quickRatio": 9.496, "currentRatio": 11.073, "totalRevenue": 32876000, "debtToEquity": 14.108, "revenuePerShare": 0.111, "returnOnAssets": -0.10955, "returnOnEquity": -0.15642999, "grossProfits": -135880000, "freeCashflow": -207588000, "operatingCashflow": -80840000, "revenueGrowth": 1.333, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -2.90242, "financialCurrency": "USD", "symbol": "ABCL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1755907128, "regularMarketTime": 1755892801, "regularMarketChangePercent": 2.09302, "regularMarketPrice": 4.39, "exchange": "NMS", "messageBoardId": "finmb_280568380", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "AbCellera Biologics Inc.", "longName": "AbCellera Biologics Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607697000000, "postMarketChangePercent": 1.1389565, "postMarketPrice": 4.44, "postMarketChange": 0.05000019, "regularMarketChange": 0.0899997, "regularMarketDayRange": "4.22 - 4.53", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 6485054, "fiftyTwoWeekLowChange": 2.4989998, "fiftyTwoWeekLowChangePercent": 1.321523, "fiftyTwoWeekRange": "1.891 - 5.82", "fiftyTwoWeekHighChange": -1.4300003, "fiftyTwoWeekHighChangePercent": -0.24570452, "fiftyTwoWeekChangePercent": 63.19703, "earningsTimestamp": 1754596800, "earningsTimestampStart": 1762200000, "earningsTimestampEnd": 1762200000, "earningsCallTimestampStart": 1754600400, "earningsCallTimestampEnd": 1754600400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.56, "epsForward": -0.66, "epsCurrentYear": -0.6025, "priceEpsCurrentYear": -7.2863064, "fiftyDayAverageChange": 0.25379992, "fiftyDayAverageChangePercent": 0.06136065, "twoHundredDayAverageChange": 1.357425, "twoHundredDayAverageChangePercent": 0.44761467, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-12-11", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "displayName": "AbCellera Biologics", "trailingPegRatio": null, "__fetch_time": "2025-08-23"}]